Bd resolves previously disclosed sec investigation

Franklin lakes, n.j. , dec. 16, 2024 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today issued the following statement: bd has reached an agreement with the u.s. securities and exchange commission (sec) to resolve the previously disclosed investigation related to prior public disclosures and sec reporting regarding the bd alaris™ system, which was acquired by bd from carefusion in 2015 and is part of the bd medication management solutions business.
BDX Ratings Summary
BDX Quant Ranking